Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

529
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
529
Cancer Prevention02:59

Cancer Prevention

7.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

751
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
751
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

348
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
348
Cancer Vaccines01:30

Cancer Vaccines

897
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
897
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

550
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
550

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-Device Adaptation of Mirai for Mammography-Based Breast Cancer Risk Prediction.

medRxiv : the preprint server for health sciences·2026
Same author

Concordance Between Maternal and Infant COVID-19 and Influenza Vaccination Status.

Pediatrics·2026
Same author

Comparative 10-year performance of mammography artificial intelligence, polygenic, and clinical breast cancer risk models in the Kaiser Permanente Research Bank.

Journal of the National Cancer Institute·2026
Same author

Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults: A Cluster Randomized Crossover Study.

JAMA network open·2026
Same author

SARS-CoV-2 Vaccination Before and During Pregnancy and Prevention of Infant COVID-19 Infection.

Pediatrics·2026
Same author

Fatty Breasts and Palpable Lumps: Diagnostic Mammogram Alone May Be Sufficient to Exclude Cancer.

Journal of breast imaging·2026

Related Experiment Video

Updated: Jan 1, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K

Haloperidol and Prostate Cancer Prevention: More Epidemiologic Research Needed.

Gary D Friedman1,2, Laurel A Habel1, Ninah Achacoso1

  • 1Division of Research, Kaiser Permanente Northern California, Oakland, CA.

The Permanente Journal
|December 20, 2019
PubMed
Summary

Haloperidol may reduce prostate cancer risk, but findings are inconsistent due to small sample sizes. Further research is needed to confirm this potential preventive association in men.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.7K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.0K

Related Experiment Videos

Last Updated: Jan 1, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.7K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.7K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.0K

Area of Science:

  • Oncology
  • Pharmacology
  • Epidemiology

Background:

  • Haloperidol exhibits antiproliferative effects on prostate cancer cells in vitro.
  • These effects are mediated through binding to the sigma 1 protein.
  • Further evidence is required to assess a potential preventive role in men.

Purpose of the Study:

  • To investigate the association between haloperidol use and prostate cancer risk.
  • To evaluate other antipsychotic drugs for similar effects on prostate cancer cells.

Main Methods:

  • Case-control study utilizing conditional logistic regression.
  • Odds ratios (ORs) were calculated, adjusting for relevant covariates.
  • In vitro testing of other antipsychotics (risperidone, quetiapine, olanzapine) for sigma 1 protein binding and growth inhibition.

Main Results:

  • Evidence for haloperidol's preventive association was inconsistent, influenced by duration of use.
  • Long-term haloperidol use (>1 year) showed a reduced odds ratio (OR=0.38) for prostate cancer.
  • Risperidone, quetiapine, and olanzapine did not demonstrate sigma 1 binding or inhibit prostate cancer cell growth.

Conclusions:

  • Ambiguous epidemiologic findings warrant further investigation into haloperidol's role in prostate cancer prevention.
  • Laboratory data support further research, but findings are insufficient for clinical recommendation.
  • Future studies should focus on larger cohorts to clarify the association.